However, similar responses were observed irrespective of Binet stage, previous therapy, IgVH mutational status and ZAP70 and CD38 expression (Table 3), suggesting that Notch targeting is effective in CLL cells despite the presence of adverse prognostic factors. Here, CD38 is linked to B-cell chronic lymphocytic leukemia.